PROGEN fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Prostatype Genomics AB manufactures, markets and sells the prognostic gene test Prostatype. It helps clinicians and patients to make correct treatment decisions. The company was founded in 2007 and is headquartered in Solna, Sweden.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
PROGEN has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company